iFluor® 647 Anti-human/ non-human primates/ mouse CD107a Antibody *H4A3*
The H4A3 monoclonal antibody binds with human/ non-human primates/ mouse CD107a, a 45 kD transmembrane protein frequently expressed on the surface of macrophages, endothelial cells, epithelial cells and activated platelets. CD107a is associated with a variety of biologically interesting macromolecules/ligands, for example, . CD107a is a fairly uncommon antibody target, with a little more than 4600 publications in the last decade. Even still, CD107a is often used in flow cytometry applications as a phenotypic marker for differentiation of cell types, particularly in the study of immunology and neuroscience. This antibody was purified through affinity chromatography and conjugated to iFluor® 647 (ex/em = 656/670 nm). It is compatible with the 640 nm laser and 667/30 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte Advanteon).
Spectrum
Open in Advanced Spectrum Viewer
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd107a antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on December 17, 2024